|
|
Xyrem (sodium oxybate)
The Food and Drug Administration approved Xyrem (sodium oxybate or gamma
hydroxybutyrate, also known as GHB) for treating a small population of
patients with narcolepsy who experience episodes of cataplexy, a condition
characterized by weak or paralyzed muscles. Because of safety concerns
associated with the use of the drug, the distribution of Xyrem will be
tightly restricted.
|
Do Not Buy Xyrem Over the
Internet
- You should not buy Xyrem over the Internet because you will
bypass important safeguards designed to protect your health
(and the health of others).
- Xyrem has special safety restrictions on how it is
distributed to the public. Also, drugs purchased from foreign
Internet sources are not the FDA-approved versions of the
drugs, and they are not subject to FDA-regulated manufacturing
controls or FDA inspection of manufacturing facilities.
To learn more about buying drugs safely, please see
|
 Back to Top 
Back to Drug Info
FDA/Center for Drug Evaluation and Research
Last Updated: December 16, 2002
Originator: OTCOM/DLIS
HTML by SJW |
